Position in DBVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20
-$7,270 QoQ
Shares Held
1
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DBVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,474,060 across 465 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in DBVT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20 | 1 | Shares | Other | 2026-05-15 | |
| 2023-12-31 | $7,290 | 7,650 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $20,334 | 14,952 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $12,223 | 7,233 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $15,769 | 10,307 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $7,626 | 4,309 | Shares | Other | 2022-11-10 | |
| 2021-12-31 | $568 | 355 | Shares | Other | 2022-02-14 | |
| 2021-06-30 | $10,335 | 1,893 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $4,239 | 1,618 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $76,330 | 44,122 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $17,080 | 3,891 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $14,515 | 3,703 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||